Category: Drug Side Effects

Victoza Class Action Lawsuit

Victoza Class Action Lawsuit

Update: LEADER Trial Finds Increased Pancreatic Cancer Risk with Victoza June 17, 2016 – A study published this month in the New England Journal of Medicine (NEJM) identified a potential increased risk of pancreatic cancer in type 2 diabetes patients treated...

Uloric Class Action Lawsuit

Uloric Class Action Lawsuit

Uloric (febuxostat) is a drug that prevents flare-ups of gout, a painful medical condition that causes severe arthritis. Although Uloric has only been on the market since 2009, lawsuits have already been filed against its manufacturer, Takeda Pharmaceuticals, for failing...

Pradaxa Class Action Lawsuit

Pradaxa Class Action Lawsuit

Pradaxa Lawsuits If you were injured by Pradaxa, you are not alone — over 2,000 Pradaxa lawsuits are pending in a federal Multi-District Litigation (MDL). Judge David R. Herndon presides over the litigation in the U.S. District Court for the...

Januvia Class Action Lawsuit

Januvia Class Action Lawsuit

Update: Diabetes Drugs Linked to Rhabdomyolysis December 1, 2017 – Januvia and other diabetes drugs in its class have been associated with a rare, life-threatening muscular disease called rhabdomyolysis, according to the FDA Adverse Event Reporting System (FAERS). Rhabdomyolysis occurs...

Janumet Class Action Lawsuit

Janumet Class Action Lawsuit

Update: FDA to Investigate Janumet / Rhabdomyolysis Link December 1, 2017 – The FDA is considering taking regulatory action over Janumet and other diabetres drugs in its class after finding an increased risk of rhabdomyolysis with the drugs, according to...

Byetta Class Action Lawsuit

Byetta Class Action Lawsuit

What is Byetta? Byetta (exenatide) is a type-2 diabetes drug that comes in a pre-filled injection pen. Byetta was developed by Amylin Pharmaceuticals from the venomous saliva of the Gila monster, a large lizard found in the American Southwest. Byetta...

Actos Class Action Lawsuit

Actos Class Action Lawsuit

Update: FDA Confirms Actos Bladder Cancer Link December 15, 2016 – FDA has updated its review of Actos, confirming that use of the drug may increase the risk of bladder cancer. While Actos labels already contain a warning about the...